These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3115334)

  • 21. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
    Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
    J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor.
    Alvarez-Mon M; de la Hera A; Gaspar ML; Orfao A; Casas J; Jordá J; Durantez A
    Acta Haematol; 1989; 81(2):91-7. PubMed ID: 2496557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the proliferative response of human B lymphocytes to low molecular weight B cell growth factor (LMW-BCGF) by fibroblast growth factors (FGFs).
    Genot E; Petit-Koskas E; Sensenbrenner M; Labourdette G; Kolb JP
    Cell Immunol; 1989 Sep; 122(2):424-39. PubMed ID: 2548739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes.
    Caligaris-Cappio F; Schena M; Bergui L; Tesio L; Riva M; Rege-Cambrin G; Funaro A; Malavasi F
    Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
    J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells.
    Uckun FM; Fauci AS; Heerema NA; Song CW; Mehta SR; Gajl-Peczalska K; Chandan M; Ambrus JL
    Blood; 1987 Oct; 70(4):1020-34. PubMed ID: 3498517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
    Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria.
    Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S
    Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
    Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
    Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and immunoregulation of human B lymphocytes.
    Kehrl JH; Muraguchi A; Falkoff RJ; Ambrus JL; Butler JL; Fauci AS
    Uremia Invest; 1984-1985; 8(3-4):157-66. PubMed ID: 6085841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
    Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
    J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
    Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
    Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight B-cell growth factor and recombinant interleukin-2 are together able to generate cytotoxic T lymphocytes with LAK activity from the bone marrow cells of children with acute lymphoblastic leukemia.
    Zhou MX; Findley HW; Ragab AH
    Blood; 1989 Sep; 74(4):1355-9. PubMed ID: 2788465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell colony formation in patients with T-cell malignancies: growth factor requirements for in-vitro proliferation of peripheral blood T-cell colony-forming cells.
    Georgoulias V; Triebel F; Kosmatopoulos C; Allouche M; Gluckman JC; Mathe G; Jasmin C
    Leuk Res; 1986; 10(4):419-27. PubMed ID: 3007873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.